Response: [adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial]

Irwin Gross and Michael Auerbach address questions related to oral vs intravenous iron substitution in cancer patients receiving erythropoiesis stimulating agen

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Möbus, Volker (VerfasserIn) , Jackisch, Christian (VerfasserIn) , Schneeweiss, Andreas (VerfasserIn) , Huober, Jens (VerfasserIn) , Lück, Hans-Joachim (VerfasserIn) , Du Bois, Andreas (VerfasserIn) , Thomssen, Christoph (VerfasserIn) , Kurbacher, Christian M. (VerfasserIn) , Kuhn, Walther (VerfasserIn) , Nitz, Ulrike A. (VerfasserIn) , Runnebaum, Ingo B. (VerfasserIn) , Hinke, Axel (VerfasserIn) , Kreienberg, Rolf (VerfasserIn) , Untch, Michael (VerfasserIn)
Dokumenttyp: Article (Journal) Editorial
Sprache:Englisch
Veröffentlicht: 28 February 2014
In: Journal of the National Cancer Institute
Year: 2014, Jahrgang: 106, Heft: 3, Pages: 452
ISSN:1460-2105
DOI:10.1093/jnci/djt452
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/jnci/djt452
Verlag, Volltext: http://www.ncbi.nlm.nih.gov/pubmed?term=24586093
Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/jnci/article/106/3/djt452/977620
Volltext
Verfasserangaben:Volker Moebus, Christian Jackisch, Andreas Schneeweiss, Jens Huober, Hans-Joachim Lueck, Andreas du Bois, Christoph Thomssen, Christian Kurbacher, Walther Kuhn, Ulrike A. Nitz, Ingo B. Runnebaum, Axel Hinke, Rolf Kreienberg, Michael Untch, AGO Breast Study Group

MARC

LEADER 00000caa a2200000 c 4500
001 847942406
003 DE-627
005 20220810035002.0
007 cr uuu---uuuuu
008 160219s2014 xx |||||o 00| ||eng c
024 7 |a 10.1093/jnci/djt452  |2 doi 
035 |a (DE-627)847942406 
035 |a (DE-576)9847942404 
035 |a (DE-599)GBV847942406 
035 |a (OCoLC)1340145348 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Möbus, Volker  |d 1953-  |e VerfasserIn  |0 (DE-588)1121145272  |0 (DE-627)874014891  |0 (DE-576)480748489  |4 aut 
245 1 0 |a Response  |b [adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial]  |c Volker Moebus, Christian Jackisch, Andreas Schneeweiss, Jens Huober, Hans-Joachim Lueck, Andreas du Bois, Christoph Thomssen, Christian Kurbacher, Walther Kuhn, Ulrike A. Nitz, Ingo B. Runnebaum, Axel Hinke, Rolf Kreienberg, Michael Untch, AGO Breast Study Group 
264 1 |c 28 February 2014 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Irwin Gross and Michael Auerbach address questions related to oral vs intravenous iron substitution in cancer patients receiving erythropoiesis stimulating agen 
700 1 |a Jackisch, Christian  |d 1960-  |e VerfasserIn  |0 (DE-588)1024193160  |0 (DE-627)71932730X  |0 (DE-576)368124908  |4 aut 
700 1 |a Schneeweiss, Andreas  |d 1961-  |e VerfasserIn  |0 (DE-588)109972554  |0 (DE-627)632849630  |0 (DE-576)327251859  |4 aut 
700 1 |a Huober, Jens  |e VerfasserIn  |0 (DE-588)1059154676  |0 (DE-627)798048239  |0 (DE-576)415183898  |4 aut 
700 1 |a Lück, Hans-Joachim  |d 1954-  |e VerfasserIn  |0 (DE-588)13225476X  |0 (DE-627)51960881X  |0 (DE-576)299034070  |4 aut 
700 1 |a Du Bois, Andreas  |e VerfasserIn  |0 (DE-588)1024068722  |0 (DE-627)719096677  |0 (DE-576)367890666  |4 aut 
700 1 |a Thomssen, Christoph  |e VerfasserIn  |0 (DE-588)1207932027  |0 (DE-627)1694239217  |4 aut 
700 1 |a Kurbacher, Christian M.  |d 1962-  |e VerfasserIn  |0 (DE-588)1079309632  |0 (DE-627)842321527  |0 (DE-576)452368081  |4 aut 
700 1 |a Kuhn, Walther  |d 1960-  |e VerfasserIn  |0 (DE-588)1043327347  |0 (DE-627)770450938  |0 (DE-576)394664507  |4 aut 
700 1 |a Nitz, Ulrike A.  |e VerfasserIn  |4 aut 
700 1 |a Runnebaum, Ingo B.  |d 1960-  |e VerfasserIn  |0 (DE-588)1111567727  |0 (DE-627)865636184  |0 (DE-576)476172144  |4 aut 
700 1 |a Hinke, Axel  |e VerfasserIn  |4 aut 
700 1 |a Kreienberg, Rolf  |d 1946-2021  |e VerfasserIn  |0 (DE-588)134263618  |0 (DE-627)566075660  |0 (DE-576)172510287  |4 aut 
700 1 |a Untch, Michael  |e VerfasserIn  |0 (DE-588)134268083  |0 (DE-627)566077914  |0 (DE-576)300413572  |4 aut 
773 0 8 |i Enthalten in  |a National Cancer Institute  |t Journal of the National Cancer Institute  |d Oxford : Oxford Univ. Press, 1941  |g Bd. 106.2014, 3, Artikel-Nummer djt452, 1 Seite  |w (DE-627)265780713  |w (DE-600)1465951-7  |w (DE-576)074959581  |x 1460-2105  |7 nnas 
773 1 8 |g volume:106  |g year:2014  |g number:3  |g pages:452  |a Response [adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial] 
787 0 8 |i Ergänzung zu  |a Gross, I.  |t RE: Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer : randomized clinical trial 
856 4 0 |u https://doi.org/10.1093/jnci/djt452  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.ncbi.nlm.nih.gov/pubmed?term=24586093  |x Verlag  |3 Volltext 
856 4 0 |u https://academic.oup.com/jnci/article/106/3/djt452/977620  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200720 
993 |a Editorial 
994 |a 2014 
998 |g 109972554  |a Schneeweiss, Andreas  |m 109972554:Schneeweiss, Andreas  |d 910000  |d 910400  |e 910000PS109972554  |e 910400PS109972554  |k 0/910000/  |k 1/910000/910400/  |p 3 
999 |a KXP-PPN847942406  |e 3725932484 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedDisp":"1941-","publisherPlace":"Oxford","publisher":"Oxford Univ. Press","dateIssuedKey":"1941"}],"pubHistory":["1.1940/41(1941) -"],"title":[{"title":"Journal of the National Cancer Institute","title_sort":"Journal of the National Cancer Institute","subtitle":"JNCI"}],"note":["Gesehen am 18.02.14"],"recId":"265780713","id":{"eki":["265780713"],"issn":["1460-2105"],"zdb":["1465951-7"]},"language":["eng"],"corporate":[{"display":"National Cancer Institute","role":"aut"}],"part":{"volume":"106","pages":"452","text":"Bd. 106.2014, 3, Artikel-Nummer djt452, 1 Seite","year":"2014","issue":"3"},"disp":"National Cancer InstituteJournal of the National Cancer Institute","titleAlt":[{"title":"Journal of the National Cancer Institute online"},{"title":"JNCI"}]}],"name":{"displayForm":["Volker Moebus, Christian Jackisch, Andreas Schneeweiss, Jens Huober, Hans-Joachim Lueck, Andreas du Bois, Christoph Thomssen, Christian Kurbacher, Walther Kuhn, Ulrike A. Nitz, Ingo B. Runnebaum, Axel Hinke, Rolf Kreienberg, Michael Untch, AGO Breast Study Group"]},"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"28 February 2014"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["847942406"],"doi":["10.1093/jnci/djt452"]},"title":[{"title":"Response","subtitle":"[adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial]","title_sort":"Response"}],"person":[{"role":"aut","display":"Möbus, Volker","given":"Volker","family":"Möbus"},{"display":"Jackisch, Christian","given":"Christian","family":"Jackisch","role":"aut"},{"display":"Schneeweiss, Andreas","given":"Andreas","family":"Schneeweiss","role":"aut"},{"role":"aut","family":"Huober","given":"Jens","display":"Huober, Jens"},{"display":"Lück, Hans-Joachim","family":"Lück","given":"Hans-Joachim","role":"aut"},{"display":"Du Bois, Andreas","family":"Du Bois","given":"Andreas","role":"aut"},{"role":"aut","display":"Thomssen, Christoph","given":"Christoph","family":"Thomssen"},{"display":"Kurbacher, Christian M.","family":"Kurbacher","given":"Christian M.","role":"aut"},{"role":"aut","given":"Walther","family":"Kuhn","display":"Kuhn, Walther"},{"family":"Nitz","given":"Ulrike A.","display":"Nitz, Ulrike A.","role":"aut"},{"role":"aut","given":"Ingo B.","family":"Runnebaum","display":"Runnebaum, Ingo B."},{"given":"Axel","family":"Hinke","display":"Hinke, Axel","role":"aut"},{"role":"aut","display":"Kreienberg, Rolf","family":"Kreienberg","given":"Rolf"},{"family":"Untch","given":"Michael","display":"Untch, Michael","role":"aut"}],"recId":"847942406","language":["eng"]} 
SRT |a MOEBUSVOLKRESPONSE2820